KLF4 and prostate carcinoma: Silencing of LINC00673 in prostate cancer cells demethylates the kruppel-like factor 4 (KLF4) gene promoter, inhibiting proliferation and reducing resistance to paclitaxel (Jiang et al., 2020b).